These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 22017263)

  • 1. Choroideremia: a review of general findings and pathogenesis.
    Coussa RG; Traboulsi EI
    Ophthalmic Genet; 2012 Jun; 33(2):57-65. PubMed ID: 22017263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations.
    Jacobson SG; Cideciyan AV; Sumaroka A; Aleman TS; Schwartz SB; Windsor EA; Roman AJ; Stone EM; MacDonald IM
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4113-20. PubMed ID: 16936131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics ‎characterization and homology modeling of the CHM gene mutation: A study on its association with choroideremia.
    Imani S; Ijaz I; Shasaltaneh MD; Fu S; Cheng J; Fu J
    Mutat Res Rev Mutat Res; 2018; 775():39-50. PubMed ID: 29555028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase.
    Esposito G; De Falco F; Tinto N; Testa F; Vitagliano L; Tandurella IC; Iannone L; Rossi S; Rinaldi E; Simonelli F; Zagari A; Salvatore F
    Hum Mutat; 2011 Dec; 32(12):1460-9. PubMed ID: 21905166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic study in a tunisian family revealed IVS1+1G>A mutation in the CHM gene.
    Ben Charfeddine I; Ben Lazreg T; Ben Rayana N; Amara A; Mamaï O; Knani L; Mili A; M'sakni A; Saad A; Ben Hadj Hamida F; Gribaa M
    Ann Biol Clin (Paris); 2015; 73(4):469-73. PubMed ID: 26411914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number variant analysis in CHM to detect duplications underlying choroideremia.
    Chi JY; MacDonald IM; Hume S
    Ophthalmic Genet; 2013 Dec; 34(4):229-33. PubMed ID: 23273018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choroideremia: molecular mechanisms and therapies.
    Sarkar H; Moosajee M
    Trends Mol Med; 2022 May; 28(5):378-387. PubMed ID: 35341685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing reveals a novel CHM gene mutation in a family with choroideremia initially diagnosed as retinitis pigmentosa.
    Guo H; Li J; Gao F; Li J; Wu X; Liu Q
    BMC Ophthalmol; 2015 Jul; 15():85. PubMed ID: 26216097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.
    Renner AB; Kellner U; Cropp E; Preising MN; MacDonald IM; van den Hurk JA; Cremers FP; Foerster MH
    Ophthalmology; 2006 Nov; 113(11):2066.e1-10. PubMed ID: 16935340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A frameshift mutation in the CHM gene causes choroideremia with acute angle‑closure glaucoma.
    Ouyang P; Li Y; Zhang F; Zhu C; Zou B; Le J; Zhang L
    Mol Med Rep; 2018 Jun; 17(6):7918-7924. PubMed ID: 29620233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel SVA retrotransposon insertion in the
    Jones KD; Radziwon A; Birch DG; MacDonald IM
    Ophthalmic Genet; 2020 Aug; 41(4):341-344. PubMed ID: 32441177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical findings in a carrier of a new mutation in the choroideremia gene.
    Potter MJ; Wong E; Szabo SM; McTaggart KE
    Ophthalmology; 2004 Oct; 111(10):1905-9. PubMed ID: 15465555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial and temporal expression patterns of the choroideremia gene in the mouse retina.
    Keiser NW; Tang W; Wei Z; Bennett J
    Mol Vis; 2005 Dec; 11():1052-60. PubMed ID: 16357828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical choroideremia presenting with early-onset macular atrophy.
    Kontos G; Kwan J; Xue K; Patrício MI; Clouston P; Packham E; MacLaren RE; Downes SM
    Acta Ophthalmol; 2019 Sep; 97(6):633-636. PubMed ID: 30690895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and functional findings in choroideremia due to complete deletion of the CHM gene.
    Mura M; Sereda C; Jablonski MM; MacDonald IM; Iannaccone A
    Arch Ophthalmol; 2007 Aug; 125(8):1107-13. PubMed ID: 17698759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual impairment and REP-1 gene mutations in Japanese choroideremia patients.
    Hayakawa M; Fujiki K; Hotta Y; Ito R; Ohki J; Ono J; Saito A; Nakayasu K; Kanai A; Ishidoh K; Kominami E; Yoshida K; Kim KC; Ohashi H
    Ophthalmic Genet; 1999 Jun; 20(2):107-15. PubMed ID: 10420196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic untreated retinal detachment in a patient with choroideremia provides insight into the disease process and potential therapy.
    Martin-Gutierrez MP; Buckley TM; MacLaren RE
    Eur J Ophthalmol; 2022 Jul; 32(4):NP30-NP33. PubMed ID: 33573424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization of the Rab-GDI/CHM superfamily: the functional basis for choroideremia disease.
    Alory C; Balch WE
    Traffic; 2001 Aug; 2(8):532-43. PubMed ID: 11489211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choroideremia: molecular mechanisms and development of AAV gene therapy.
    Patrício MI; Barnard AR; Xue K; MacLaren RE
    Expert Opin Biol Ther; 2018 Jul; 18(7):807-820. PubMed ID: 29932012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity of a novel missense variant associated with choroideremia and its impact on gene replacement therapy.
    Torriano S; Erkilic N; Faugère V; Damodar K; Hamel CP; Roux AF; Kalatzis V
    Hum Mol Genet; 2017 Sep; 26(18):3573-3584. PubMed ID: 28911202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.